go back

Chemotherapy, Acute Leukemia or High-Dose Agent (with MCC)

New Jersey rates for MS-DRG 837

Chemotherapy with Acute Leukemia as Secondary Diagnosis or with High Dose Chemotherapy Agent with MCC

Rates data updated July 2026.

How much does Chemotherapy, Acute Leukemia or High-Dose Agent (with MCC) cost?

$109,648

Typical facility fee. In New Jersey, July 2026.

Insurers have agreed to pay about $109,648 for this service. Most negotiated rates run $81,283 to $131,826.

These are rates insurers have negotiated with providers, not the amount a patient is billed. What you owe depends on your plan's deductible and coinsurance. Based on rates published by 4 insurance carriers under federal price transparency rules.

How much rates vary

Facilitymedian $109,648 · 10th to 90th $57,544 to $154,882
$10K$20K$50K$100K$200Kfacility $109,648

Distribution of negotiated rates across all payers (price axis is log-scale). Each curve is scaled to its own total: facility and professional rates are different services, shown together to compare where they cluster. Need provider-level prices or 24+ months of history? Contact us.

Rates by insurance carrier

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$72,443.60
Median
$114,815.36
Typical High
$154,881.66
Cigna
Setting
Facility
Modifier
Global
Typical Low
$56,234.13
Median
$117,489.76
Typical High
$154,881.66
Horizon BCBS
Setting
Facility
Modifier
Global
Typical Low
$66,069.34
Median
$104,712.85
Typical High
$151,356.12
United
Setting
Facility
Modifier
Global
Typical Low
$6,025.60
Median
$20,892.96
Typical High
$131,825.67

Where New Jersey sits

The same service costs 6.2 times more in Colorado than in West Virginia. Every bar is a state, most expensive first. Touch or drag across it to read any state, then open that state for its carriers and full range.

New Jersey· 7th of 51

$109,648

CO $123,027WV $19,953

Median negotiated rate in each state, from every insurer that publishes one. States where no insurer publishes a rate for this service are not shown.